A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT01380769 · COMPLETED

Trial details

NCT number: NCT01380769
Sponsor: NewLink Genetics Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2011-06-01
Primary completion: 2013-02-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.